Skip to content

Research on the Efficacy of a New Strategy Based on SAINT for Treating Suicidal and Self-Injurious Behaviors in Adolescents with Depressive Disorders

Research on the Efficacy of a New Strategy Based on SAINT for Treating Suicidal and Self-Injurious Behaviors in Adolescents with Depressive Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115057
Enrollment
Unknown
Registered
2025-12-22
Start date
2025-12-22
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Depression

Interventions

treatment group:Stanford Accelerated Therapy: Intermittent Theta Burst Stimulation (iTMS)

Sponsors

Suzhou Guangji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.DSM-V Depression Diagnostic Criteria 2.Individuals who have not received systematic and formal treatment with psychiatric medications, including antidepressants and mood stabilizers, or those who have experienced poor treatment outcomes. 3.HAMD-24 score >24, item 3 >3; Beck Scale for Suicidal Ideation total score =12 4.Individuals who sign the informed consent form

Exclusion criteria

Exclusion criteria: 1.The patient had previously received repetitive transcranial magnetic stimulation (rTMS), vagus nerve stimulation, or electroconvulsive therapy before enrollment. 2.rTMS contraindications: cardiac pacemaker, implanted drug pump, intracardiac metal wire; 3.Acute exacerbation of chronic diseases: such as chronic obstructive pulmonary disease, asthma, hypertension (>140/95 mmHg), heart disease, liver disease, blood disorders, diabetes, tachycardia (resting heart rate >95 beats/min); 4.Neurological diseases: including cerebrovascular diseases, brain tumors, traumatic brain injuries, multiple sclerosis, epilepsy, movement disorders, and migraine during treatment; 5.Currently using respiratory medications, cardiovascular drugs, anticonvulsants, or psychoactive substances; substance abuse and dependence; 6.Depression secondary to general medical conditions or triggering substances; intellectual disability; 7.Unable to locate and quantify the exercise threshold 8. All subjects signed an informed consent form prior to enrolment.

Design outcomes

Primary

MeasureTime frame
HAMD score;

Countries

CHINA

Contacts

Public ContactYuyan Chi

Suzhou Guangji Hospital

psy_cyy4660@163.com+86 199 5131 6715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026